INTRODUCTION
The Medicinal Products: Presctibino by Nurses Act (/992) is in existence, permitting certain groups of nurses prescribing rights for a limited formulary of products. Why should the nursing profession be seeking prescribing rights? Meeting chairman Dr Graham Burton (Zeneca) identified the trend to increasing specialization of the nurse's role, and that many more nurses undertake postgraduate research in their chosen specialization, leading to an increased amount of clinical responsibility in practice. Nurse practitioners are valued members of the primary care team, underpinning the work of general practice. Experienced, specialist, hospitalbased nurses and community-based nurse practitioners for example, school nurses, have been involved in the prescribing decision in some way for a long time.
HOW THE ACT CAME ABOUT
The Medicinal Products: Prescribino by Nurses Act (/992) was the culmination of nearly 10 years' work on the issues surrounding nurse prescribing. The Royal College of Nursing (RCN) had a considerable input into the process leading to the 1992 Act. The Cumberled8e Report was produced in 1986, and a similar exercise was carried out for Wales (The Edward Report, published in 1987) . Mark Jones (Adviser in Community Medicine to the Royal College of Nursing) noted that on the recommendation of the Commons Social Services Select Committee, the 1989 Crown Report based on the previous studies limited nurse prescribing rights to two groups. These were qualified district nurses and qualified health visitors. No provision was made for nurse practitioners and health centre nurses and the RCN considered this an unfortunate omission. The formulary recommendations in the Crown Report were also unsatisfactory. In many general practices, whether fundholders or not, a working protocol exists that permits practice nurses to prescribe certain products from the formulary already agreed with their general practitioner (GP) colleagues. A GP will sign a number of 'FPlOs' which are then used in the practice clinics. 'Prescribing by default' , as this is known, is considered an unsatisfactory arrangement by the nursing profession in a number of ways and the RCN actively sought extension of prescribing rights to nurse practItioners and health centre nurses. 
PILOT PROJECTS IN NURSE PRESCRIBING
According to the Act, registered nurses, health visitors and midwives are 'appropriate practitioners' and can prescribe products from the agreed formulary. The Act gives the Secretary of State the power to limit the formulary and to set categories. However, nurse prescribing was not yet a reality. The Government felt that too little was known still about the cost implications of extending the nurse formulary and the effect of nurse prescribing on the quality of care. A limited programme of nurse prescribing from a generic formulary began in October 1994, with the aim of obtaining information on the impact of nurse prescribing on quality of care, time-saving and cost-benefits. The success of proposals to extend the nurse formulary depends very much on the pilots' success. Eight pilot projects involving eight fund holding sites and 56 qualified community nurses are involved. Nurses received a distance learning training package of 15 h and attended a 2-day residential course before joining the project. The pilot projects trace prescribing expenditure and depend on 'zero budget' generic prescribing from a limited formulary to keep costs down. The University of York and the University of Liverpool are analysing the studies for cost benefit, timesaving and the qualitative aspects to find out how nurses and patients feel about it. The analysis will also record how often GPs issued a prescription when, if possible, they would like nurses to do so. Mark Jones commented on the need to expand the formulary for nurse prescribers. 'The RCGP, the RCN, SMA and RPSGB have to achieve a consensus on the issue of prescribing rights.'
THE VIEW FROM GENERAL PRACTICE
Many GPs are enthusiastic about nurse prescribing because it has the potential for time-saving, is good for primary care, good for nurses and patients and recognizes nurses' expertise. Negative responses seem to arise from an underlying concern about the implied threat to the autonomy of the profession. Is the loss of exclusivity of prescribing going to fragment and dilute the GP's role?
Peter Cantelon (lecturer in general practice at Guy's Hospital) noted concerns that GPs could lose out through lack of exposure to acute cases and chronic care patients, and care of the terminally ill. Already nurses take on more of the health promotion and preventative care role than GPs, ll8P pharmacists are seeking an expanded role, and there are increasing numbers of alternative practitioners and counsellors. He feels the GP's position is secure.
There will always be a need for a generalist in community practice, fulfilling several roles. The GP acts as director for the rest of the team, as a resource fund of knowledge, a mediator between patients and their illnesses.
It is also important for patients to know that their record and family history resides in one person. The GP is the repository for contextual knowledge and this is properly part of the patient-physician relationship. Peter Cantelon identified a need for recognized training in clinical assessment for nurse prescribers.
To promote quality prescribing you must address the issues that relate to diagnostic accuracy. How to distinguish between presenting patients for accurate prescribing for example.
Responsibility and accountability for clinical decisionmaking at the moment rests with the GP. 'Should nurses take on their own indemnity?' he asked.
THE PHARMACY PROFESSION AND THE NURSE PRESCRIBER
The Royal Pharmaceutical Society of Great Britain (RPSGB) edits the nurse formulary for the British National Formulary (BNF) prescribing sub-committee (NPF). A review of the expansion of the nurse prescribing list will be needed, and the RPSGB will be happy to collaborate on a number of associated topics. Alan Nathan (Chair of the Practitioner Committee, Royal College Department of Pharmacy, King's College Hospital) suggested that the RPSGB could playa useful educational role in nurse training through the schools of pharmacy and centres for postgraduate education in pharmacy. Practice level contacts for the pharmacist with the nurse prescriber and meetings to establish closer working communications between their roles would also be mutually useful, especially in an emergency. The pharmacists can also advise on de-regulation of medicines and on over-the-counter products in the case of generic prescriptions. Alan Nathan emphasized that pharmacists have no financial interests in nurse prescribing. Any benefits to pharmacy over those for patients are time saved on prescribing enquiries, the chance for checks on compliance, and to develop a good working partnership with the nurse prescriber to benefit communications in primary care.
COMMUNITY NURSE PRESCRIBING-VIEW OF THE SUPPLIER
According to Carin8]or People NHS Community Care White Paper, there are 127 000 people in the primary healthcare team in the UK. The community nurse is a valued and important member of that team as measured by the perception of the community nurse by patients, by their influence on the GP, the hospital patient and pharmacists. Information and education for nurses is a large part of the supplier's role. Ian Lindridge (Marketing Manager of Seton Healthcare) explained that his company has two sales teams, one for semi-ethical products relevant to nursing practice. He views nurse education in the use of these products as well worth his company's !ime. Nurses need upto-date, clear and balanced information about products and this information must be relevant to the way that nurses will use these products in practice.
Community nurses want efficacy, safety and cost effectiveness of the products they recommend, he noted.
Doctors in general place greater emphasiS on cost-benefit and clinical innovation while nurses would emphasize the quality of life cllccts and durability and efficacy of the. product.
SUMMARY OF CONCLUSIONS
1 Nurse prescribing is here to stay and should be extended to all community-based nurses 2 There is a need for a unified training package, for example containing information on pharmacology, and on the legal and educational aspects of prescribing for patients 3 A larger and more comprehensive formulary customized to the nurse speciality should be a priority 4 The nursing profession and general practitioners need to work together on guidelines and protocols for nurse prescribing, with respect for each other's autonomy 5 In the future, shared accountability and shared audit practices will develop, built on trust between the partnerships in primary care.
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